Walsh Matthew M

Avg. Two Year Performance

< 1% Avg. Purchase Return
0% Compound
(9%) Avg. Sale Return
(4%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)(5%)14%(9%)< 1%
Purchase Success Rate2 of 31 of 32 of 31 of 31 of 3
Average Sale Return6%9%17%6%(9%)
Sale Success Rate2 of 43 of 43 of 43 of 41 of 4
Other » Other

CFO AND EXE. V.P.:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

EVP, Chief Financial Officer:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drugs - Generic

EVP & Chief Financial Officer:

Holdings: 103.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Chief Financial Officer:

Holdings: 14.69K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Diversified Services » Business Services

Director:

Holdings: 1.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 179.96K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--